+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
ID05831345

Use of Methadone During Orthopedic Surgery to Improve Postoperative Pain Control Compared to Sufentanil A Randomized, Double-Blind Phase 3 Study in Adults Aged 18 to 80

Led by Brugmann University Hospital · Updated on 2025-02-07

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying pain control after orthopedic surgery when locoregional anesthesia cannot be used. This trial compares intraoperative methadone, known for its long half-life, with sufentanil to see which provides better pain relief during the first 24 hours after surgery. The study focuses on patients undergoing elective hip or knee arthroplasty and aims to evaluate if methadone can reduce pain without increasing opioid-related side effects. Participants are randomly assigned to receive either methadone or sufentanil during the induction of general anesthesia. Both drugs are administered as part of the standard anesthesia process, with the medical team blinded to which opioid is given. The study is double-blind and compares total morphine use and pain scores within 24 to 72 hours after surgery. During the 72-hour postoperative period, researchers will assess total morphine consumption and patient-reported pain using a visual analogue scale. Patient satisfaction with pain control is also measured. Participants will be monitored for any opioid-related adverse events. The study includes adults aged 18 to 80 years undergoing elective orthopedic surgery and excludes those with kidney or liver issues, heart failure, opioid use history, or pregnancy.

CONDITIONS

Brief Title

Intraoperative Methadone for the Prevention of Postoperative Pain

Research Team

R

Riccardo Mora, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here